nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ABCB1—colon cancer	0.249	1	CbGaD
Phenytoin—SLCO1C1—Methotrexate—colon cancer	0.0845	0.15	CbGbCtD
Phenytoin—ABCC2—Irinotecan—colon cancer	0.0456	0.0809	CbGbCtD
Phenytoin—ABCC2—Vincristine—colon cancer	0.0399	0.0707	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0305	0.054	CbGbCtD
Phenytoin—CYP3A7—Irinotecan—colon cancer	0.0305	0.054	CbGbCtD
Phenytoin—CYP2B6—Irinotecan—colon cancer	0.029	0.0514	CbGbCtD
Phenytoin—ALB—Irinotecan—colon cancer	0.0284	0.0504	CbGbCtD
Phenytoin—ALB—Fluorouracil—colon cancer	0.0273	0.0484	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0266	0.0472	CbGbCtD
Phenytoin—CYP3A7—Vincristine—colon cancer	0.0266	0.0472	CbGbCtD
Phenytoin—CYP2C9—Capecitabine—colon cancer	0.0248	0.044	CbGbCtD
Phenytoin—ABCC2—Methotrexate—colon cancer	0.0241	0.0428	CbGbCtD
Phenytoin—CYP3A5—Irinotecan—colon cancer	0.0228	0.0405	CbGbCtD
Phenytoin—CYP2C8—Fluorouracil—colon cancer	0.0211	0.0374	CbGbCtD
Phenytoin—CYP3A5—Vincristine—colon cancer	0.02	0.0354	CbGbCtD
Phenytoin—ALB—Methotrexate—colon cancer	0.015	0.0267	CbGbCtD
Phenytoin—ABCB1—Irinotecan—colon cancer	0.0149	0.0264	CbGbCtD
Phenytoin—CYP2C9—Fluorouracil—colon cancer	0.0147	0.0261	CbGbCtD
Phenytoin—ABCB1—Vincristine—colon cancer	0.013	0.0231	CbGbCtD
Phenytoin—CYP3A4—Irinotecan—colon cancer	0.00891	0.0158	CbGbCtD
Phenytoin—ABCB1—Methotrexate—colon cancer	0.00787	0.014	CbGbCtD
Phenytoin—CYP3A4—Vincristine—colon cancer	0.00779	0.0138	CbGbCtD
Phenytoin—ABCC2—bile—colon cancer	0.00411	0.16	CbGeAlD
Phenytoin—ALB—gall bladder—colon cancer	0.00122	0.0474	CbGeAlD
Phenytoin—SLCO1C1—renal system—colon cancer	0.00102	0.0399	CbGeAlD
Phenytoin—SCN4A—renal system—colon cancer	0.00094	0.0366	CbGeAlD
Phenytoin—CYP2C18—digestive system—colon cancer	0.000907	0.0353	CbGeAlD
Phenytoin—CYP2C18—vagina—colon cancer	0.000801	0.0312	CbGeAlD
Phenytoin—SCN3A—renal system—colon cancer	0.000731	0.0285	CbGeAlD
Phenytoin—CYP2C18—liver—colon cancer	0.000676	0.0263	CbGeAlD
Phenytoin—CYP3A7—liver—colon cancer	0.000643	0.025	CbGeAlD
Phenytoin—SCN2A—vagina—colon cancer	0.000603	0.0235	CbGeAlD
Phenytoin—SCN5A—digestive system—colon cancer	0.000598	0.0233	CbGeAlD
Phenytoin—SCN3A—bone marrow—colon cancer	0.000553	0.0215	CbGeAlD
Phenytoin—ABCC2—renal system—colon cancer	0.000547	0.0213	CbGeAlD
Phenytoin—CYP3A7-CYP3A51P—liver—colon cancer	0.000547	0.0213	CbGeAlD
Phenytoin—SCN3A—vagina—colon cancer	0.00053	0.0206	CbGeAlD
Phenytoin—SCN5A—vagina—colon cancer	0.000528	0.0206	CbGeAlD
Phenytoin—SCN9A—lymph node—colon cancer	0.000494	0.0192	CbGeAlD
Phenytoin—SLCO1C1—lymph node—colon cancer	0.000479	0.0187	CbGeAlD
Phenytoin—ABCC2—digestive system—colon cancer	0.000449	0.0175	CbGeAlD
Phenytoin—ABCB1—blood vessel—colon cancer	0.000436	0.017	CbGeAlD
Phenytoin—CYP2C8—renal system—colon cancer	0.00041	0.016	CbGeAlD
Phenytoin—CYP2C19—digestive system—colon cancer	0.000386	0.015	CbGeAlD
Phenytoin—CYP3A5—renal system—colon cancer	0.00037	0.0144	CbGeAlD
Phenytoin—CYP2B6—renal system—colon cancer	0.000368	0.0143	CbGeAlD
Phenytoin—ALB—liver—colon cancer	0.000357	0.0139	CbGeAlD
Phenytoin—SCN3A—lymph node—colon cancer	0.000343	0.0133	CbGeAlD
Phenytoin—CYP2C19—vagina—colon cancer	0.00034	0.0133	CbGeAlD
Phenytoin—ABCC2—liver—colon cancer	0.000334	0.013	CbGeAlD
Phenytoin—CYP2B6—lymphoid tissue—colon cancer	0.000306	0.0119	CbGeAlD
Phenytoin—CYP3A5—digestive system—colon cancer	0.000304	0.0118	CbGeAlD
Phenytoin—CYP2B6—digestive system—colon cancer	0.000302	0.0118	CbGeAlD
Phenytoin—CYP2C9—digestive system—colon cancer	0.000299	0.0116	CbGeAlD
Phenytoin—Oxaprozin—PTGS2—colon cancer	0.000299	0.41	CrCbGaD
Phenytoin—CYP2C8—vagina—colon cancer	0.000297	0.0116	CbGeAlD
Phenytoin—CYP2C19—liver—colon cancer	0.000287	0.0112	CbGeAlD
Phenytoin—CYP3A4—renal system—colon cancer	0.000278	0.0108	CbGeAlD
Phenytoin—ALB—lymph node—colon cancer	0.000274	0.0107	CbGeAlD
Phenytoin—CYP3A5—vagina—colon cancer	0.000268	0.0104	CbGeAlD
Phenytoin—CYP2B6—vagina—colon cancer	0.000267	0.0104	CbGeAlD
Phenytoin—ABCB1—embryo—colon cancer	0.00026	0.0101	CbGeAlD
Phenytoin—ABCC2—lymph node—colon cancer	0.000256	0.00998	CbGeAlD
Phenytoin—CYP2C8—liver—colon cancer	0.000251	0.00977	CbGeAlD
Phenytoin—Polyuria—Methotrexate—colon cancer	0.000248	0.00169	CcSEcCtD
Phenytoin—Ill-defined disorder—Irinotecan—colon cancer	0.000244	0.00166	CcSEcCtD
Phenytoin—Anaemia—Irinotecan—colon cancer	0.000243	0.00166	CcSEcCtD
Phenytoin—Bronchitis—Capecitabine—colon cancer	0.000243	0.00166	CcSEcCtD
Phenytoin—Vertigo—Vincristine—colon cancer	0.000243	0.00166	CcSEcCtD
Phenytoin—Leukopenia—Vincristine—colon cancer	0.000242	0.00165	CcSEcCtD
Phenytoin—Pancytopenia—Capecitabine—colon cancer	0.00024	0.00164	CcSEcCtD
Phenytoin—Malaise—Irinotecan—colon cancer	0.000237	0.00162	CcSEcCtD
Phenytoin—Vertigo—Irinotecan—colon cancer	0.000236	0.00161	CcSEcCtD
Phenytoin—Dysuria—Capecitabine—colon cancer	0.000236	0.00161	CcSEcCtD
Phenytoin—Syncope—Irinotecan—colon cancer	0.000236	0.00161	CcSEcCtD
Phenytoin—Leukopenia—Irinotecan—colon cancer	0.000235	0.00161	CcSEcCtD
Phenytoin—Convulsion—Vincristine—colon cancer	0.000234	0.0016	CcSEcCtD
Phenytoin—Hypertension—Vincristine—colon cancer	0.000233	0.00159	CcSEcCtD
Phenytoin—Anaemia—Fluorouracil—colon cancer	0.000233	0.00159	CcSEcCtD
Phenytoin—Loss of consciousness—Irinotecan—colon cancer	0.000231	0.00158	CcSEcCtD
Phenytoin—Photosensitivity reaction—Capecitabine—colon cancer	0.000231	0.00157	CcSEcCtD
Phenytoin—Myalgia—Vincristine—colon cancer	0.00023	0.00157	CcSEcCtD
Phenytoin—Cough—Irinotecan—colon cancer	0.00023	0.00157	CcSEcCtD
Phenytoin—Weight decreased—Capecitabine—colon cancer	0.000229	0.00156	CcSEcCtD
Phenytoin—CYP3A4—digestive system—colon cancer	0.000228	0.00888	CbGeAlD
Phenytoin—Hyperglycaemia—Capecitabine—colon cancer	0.000228	0.00155	CcSEcCtD
Phenytoin—Hypertension—Irinotecan—colon cancer	0.000227	0.00155	CcSEcCtD
Phenytoin—Pneumonia—Capecitabine—colon cancer	0.000227	0.00155	CcSEcCtD
Phenytoin—CYP3A5—liver—colon cancer	0.000226	0.00881	CbGeAlD
Phenytoin—Leukopenia—Fluorouracil—colon cancer	0.000226	0.00154	CcSEcCtD
Phenytoin—CYP2B6—liver—colon cancer	0.000225	0.00876	CbGeAlD
Phenytoin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000225	0.00153	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000223	0.00152	CcSEcCtD
Phenytoin—CYP2C9—liver—colon cancer	0.000223	0.00868	CbGeAlD
Phenytoin—Renal failure—Capecitabine—colon cancer	0.000221	0.00151	CcSEcCtD
Phenytoin—Discomfort—Irinotecan—colon cancer	0.000221	0.00151	CcSEcCtD
Phenytoin—Anaphylactic shock—Vincristine—colon cancer	0.00022	0.0015	CcSEcCtD
Phenytoin—Infection—Vincristine—colon cancer	0.000219	0.00149	CcSEcCtD
Phenytoin—Conjunctivitis—Capecitabine—colon cancer	0.000219	0.00149	CcSEcCtD
Phenytoin—Convulsion—Fluorouracil—colon cancer	0.000218	0.00149	CcSEcCtD
Phenytoin—Osteoarthritis—Methotrexate—colon cancer	0.000218	0.00148	CcSEcCtD
Phenytoin—Confusional state—Irinotecan—colon cancer	0.000216	0.00148	CcSEcCtD
Phenytoin—Nervous system disorder—Vincristine—colon cancer	0.000216	0.00147	CcSEcCtD
Phenytoin—Thrombocytopenia—Vincristine—colon cancer	0.000216	0.00147	CcSEcCtD
Phenytoin—Anaphylactic shock—Irinotecan—colon cancer	0.000215	0.00146	CcSEcCtD
Phenytoin—Myalgia—Fluorouracil—colon cancer	0.000214	0.00146	CcSEcCtD
Phenytoin—Chest pain—Fluorouracil—colon cancer	0.000214	0.00146	CcSEcCtD
Phenytoin—Infection—Irinotecan—colon cancer	0.000213	0.00145	CcSEcCtD
Phenytoin—Hyperhidrosis—Vincristine—colon cancer	0.000213	0.00145	CcSEcCtD
Phenytoin—Hepatobiliary disease—Capecitabine—colon cancer	0.000213	0.00145	CcSEcCtD
Phenytoin—Epistaxis—Capecitabine—colon cancer	0.000212	0.00145	CcSEcCtD
Phenytoin—ABCB1—epithelium—colon cancer	0.000212	0.00826	CbGeAlD
Phenytoin—Discomfort—Fluorouracil—colon cancer	0.000212	0.00145	CcSEcCtD
Phenytoin—Shock—Irinotecan—colon cancer	0.000211	0.00144	CcSEcCtD
Phenytoin—Nervous system disorder—Irinotecan—colon cancer	0.000211	0.00144	CcSEcCtD
Phenytoin—Agranulocytosis—Capecitabine—colon cancer	0.00021	0.00143	CcSEcCtD
Phenytoin—Thrombocytopenia—Irinotecan—colon cancer	0.00021	0.00143	CcSEcCtD
Phenytoin—Anorexia—Vincristine—colon cancer	0.00021	0.00143	CcSEcCtD
Phenytoin—Irritability—Methotrexate—colon cancer	0.000208	0.00142	CcSEcCtD
Phenytoin—Hyperhidrosis—Irinotecan—colon cancer	0.000208	0.00142	CcSEcCtD
Phenytoin—Confusional state—Fluorouracil—colon cancer	0.000207	0.00141	CcSEcCtD
Phenytoin—Mood swings—Methotrexate—colon cancer	0.000206	0.00141	CcSEcCtD
Phenytoin—Hypotension—Vincristine—colon cancer	0.000206	0.00141	CcSEcCtD
Phenytoin—Bradycardia—Capecitabine—colon cancer	0.000206	0.0014	CcSEcCtD
Phenytoin—Anaphylactic shock—Fluorouracil—colon cancer	0.000206	0.0014	CcSEcCtD
Phenytoin—Anorexia—Irinotecan—colon cancer	0.000205	0.0014	CcSEcCtD
Phenytoin—Ataxia—Methotrexate—colon cancer	0.000205	0.0014	CcSEcCtD
Phenytoin—Infection—Fluorouracil—colon cancer	0.000204	0.00139	CcSEcCtD
Phenytoin—Haemoglobin—Capecitabine—colon cancer	0.000203	0.00139	CcSEcCtD
Phenytoin—Rhinitis—Capecitabine—colon cancer	0.000203	0.00138	CcSEcCtD
Phenytoin—Haemorrhage—Capecitabine—colon cancer	0.000202	0.00138	CcSEcCtD
Phenytoin—Nervous system disorder—Fluorouracil—colon cancer	0.000202	0.00138	CcSEcCtD
Phenytoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Hypoaesthesia—Capecitabine—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Liver function test abnormal—Methotrexate—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Pharyngitis—Capecitabine—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Tachycardia—Fluorouracil—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Hypotension—Irinotecan—colon cancer	0.000201	0.00137	CcSEcCtD
Phenytoin—Insomnia—Vincristine—colon cancer	0.000199	0.00136	CcSEcCtD
Phenytoin—Connective tissue disorder—Capecitabine—colon cancer	0.000199	0.00136	CcSEcCtD
Phenytoin—Paraesthesia—Vincristine—colon cancer	0.000198	0.00135	CcSEcCtD
Phenytoin—Phenylbutazone—PTGS2—colon cancer	0.000198	0.271	CrCbGaD
Phenytoin—ABCB1—renal system—colon cancer	0.000197	0.00766	CbGeAlD
Phenytoin—Breast disorder—Methotrexate—colon cancer	0.000197	0.00134	CcSEcCtD
Phenytoin—Anorexia—Fluorouracil—colon cancer	0.000196	0.00134	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000196	0.00134	CcSEcCtD
Phenytoin—Insomnia—Irinotecan—colon cancer	0.000194	0.00132	CcSEcCtD
Phenytoin—Paraesthesia—Irinotecan—colon cancer	0.000193	0.00132	CcSEcCtD
Phenytoin—Hypotension—Fluorouracil—colon cancer	0.000192	0.00131	CcSEcCtD
Phenytoin—Decreased appetite—Vincristine—colon cancer	0.000192	0.00131	CcSEcCtD
Phenytoin—Dyspnoea—Irinotecan—colon cancer	0.000191	0.00131	CcSEcCtD
Phenytoin—Erythema multiforme—Capecitabine—colon cancer	0.000191	0.0013	CcSEcCtD
Phenytoin—Somnolence—Irinotecan—colon cancer	0.000191	0.0013	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Vincristine—colon cancer	0.00019	0.0013	CcSEcCtD
Phenytoin—Fatigue—Vincristine—colon cancer	0.00019	0.0013	CcSEcCtD
Phenytoin—Dyspepsia—Irinotecan—colon cancer	0.000189	0.00129	CcSEcCtD
Phenytoin—Tinnitus—Capecitabine—colon cancer	0.000189	0.00129	CcSEcCtD
Phenytoin—Constipation—Vincristine—colon cancer	0.000189	0.00129	CcSEcCtD
Phenytoin—Asthma—Methotrexate—colon cancer	0.000188	0.00128	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000187	0.00128	CcSEcCtD
Phenytoin—Decreased appetite—Irinotecan—colon cancer	0.000187	0.00127	CcSEcCtD
Phenytoin—Eosinophilia—Methotrexate—colon cancer	0.000186	0.00127	CcSEcCtD
Phenytoin—Insomnia—Fluorouracil—colon cancer	0.000186	0.00127	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000185	0.00126	CcSEcCtD
Phenytoin—Fatigue—Irinotecan—colon cancer	0.000185	0.00126	CcSEcCtD
Phenytoin—Paraesthesia—Fluorouracil—colon cancer	0.000185	0.00126	CcSEcCtD
Phenytoin—Constipation—Irinotecan—colon cancer	0.000184	0.00125	CcSEcCtD
Phenytoin—Dyspnoea—Fluorouracil—colon cancer	0.000183	0.00125	CcSEcCtD
Phenytoin—Somnolence—Fluorouracil—colon cancer	0.000183	0.00125	CcSEcCtD
Phenytoin—Immune system disorder—Capecitabine—colon cancer	0.000183	0.00125	CcSEcCtD
Phenytoin—Chills—Capecitabine—colon cancer	0.000181	0.00124	CcSEcCtD
Phenytoin—Dyspepsia—Fluorouracil—colon cancer	0.000181	0.00123	CcSEcCtD
Phenytoin—Decreased appetite—Fluorouracil—colon cancer	0.000179	0.00122	CcSEcCtD
Phenytoin—Pancytopenia—Methotrexate—colon cancer	0.000179	0.00122	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000178	0.00121	CcSEcCtD
Phenytoin—Feeling abnormal—Irinotecan—colon cancer	0.000177	0.00121	CcSEcCtD
Phenytoin—Dysuria—Methotrexate—colon cancer	0.000176	0.0012	CcSEcCtD
Phenytoin—Body temperature increased—Vincristine—colon cancer	0.000174	0.00119	CcSEcCtD
Phenytoin—Flatulence—Capecitabine—colon cancer	0.000173	0.00118	CcSEcCtD
Phenytoin—Dysgeusia—Capecitabine—colon cancer	0.000172	0.00118	CcSEcCtD
Phenytoin—Photosensitivity reaction—Methotrexate—colon cancer	0.000172	0.00117	CcSEcCtD
Phenytoin—Back pain—Capecitabine—colon cancer	0.00017	0.00116	CcSEcCtD
Phenytoin—CYP3A4—liver—colon cancer	0.00017	0.00662	CbGeAlD
Phenytoin—Body temperature increased—Irinotecan—colon cancer	0.00017	0.00116	CcSEcCtD
Phenytoin—Feeling abnormal—Fluorouracil—colon cancer	0.000169	0.00116	CcSEcCtD
Phenytoin—Muscle spasms—Capecitabine—colon cancer	0.000169	0.00115	CcSEcCtD
Phenytoin—Pneumonia—Methotrexate—colon cancer	0.000169	0.00115	CcSEcCtD
Phenytoin—Drowsiness—Methotrexate—colon cancer	0.000168	0.00114	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000166	0.00113	CcSEcCtD
Phenytoin—Tremor—Capecitabine—colon cancer	0.000165	0.00113	CcSEcCtD
Phenytoin—Renal failure—Methotrexate—colon cancer	0.000165	0.00112	CcSEcCtD
Phenytoin—ABCB1—lymphoid tissue—colon cancer	0.000163	0.00636	CbGeAlD
Phenytoin—Ill-defined disorder—Capecitabine—colon cancer	0.000163	0.00111	CcSEcCtD
Phenytoin—Urticaria—Fluorouracil—colon cancer	0.000163	0.00111	CcSEcCtD
Phenytoin—Conjunctivitis—Methotrexate—colon cancer	0.000163	0.00111	CcSEcCtD
Phenytoin—Anaemia—Capecitabine—colon cancer	0.000163	0.00111	CcSEcCtD
Phenytoin—Body temperature increased—Fluorouracil—colon cancer	0.000163	0.00111	CcSEcCtD
Phenytoin—Hypersensitivity—Vincristine—colon cancer	0.000162	0.00111	CcSEcCtD
Phenytoin—ABCB1—digestive system—colon cancer	0.000161	0.00629	CbGeAlD
Phenytoin—Sweating—Methotrexate—colon cancer	0.000161	0.0011	CcSEcCtD
Phenytoin—Malaise—Capecitabine—colon cancer	0.000159	0.00108	CcSEcCtD
Phenytoin—Hepatobiliary disease—Methotrexate—colon cancer	0.000159	0.00108	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Vertigo—Capecitabine—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Hypersensitivity—Irinotecan—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Asthenia—Vincristine—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Syncope—Capecitabine—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Leukopenia—Capecitabine—colon cancer	0.000158	0.00108	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—colon cancer	0.000157	0.00107	CcSEcCtD
Phenytoin—Palpitations—Capecitabine—colon cancer	0.000156	0.00106	CcSEcCtD
Phenytoin—Loss of consciousness—Capecitabine—colon cancer	0.000155	0.00106	CcSEcCtD
Phenytoin—Asthenia—Irinotecan—colon cancer	0.000154	0.00105	CcSEcCtD
Phenytoin—Cough—Capecitabine—colon cancer	0.000154	0.00105	CcSEcCtD
Phenytoin—Hypertension—Capecitabine—colon cancer	0.000152	0.00104	CcSEcCtD
Phenytoin—Hypersensitivity—Fluorouracil—colon cancer	0.000151	0.00103	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—colon cancer	0.000151	0.00103	CcSEcCtD
Phenytoin—Diarrhoea—Vincristine—colon cancer	0.000151	0.00103	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—colon cancer	0.000151	0.00103	CcSEcCtD
Phenytoin—Chest pain—Capecitabine—colon cancer	0.00015	0.00102	CcSEcCtD
Phenytoin—Arthralgia—Capecitabine—colon cancer	0.00015	0.00102	CcSEcCtD
Phenytoin—Myalgia—Capecitabine—colon cancer	0.00015	0.00102	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—colon cancer	0.000149	0.00102	CcSEcCtD
Phenytoin—ABCB1—bone marrow—colon cancer	0.000149	0.00579	CbGeAlD
Phenytoin—Discomfort—Capecitabine—colon cancer	0.000148	0.00101	CcSEcCtD
Phenytoin—Diarrhoea—Irinotecan—colon cancer	0.000147	0.001	CcSEcCtD
Phenytoin—Dry mouth—Capecitabine—colon cancer	0.000147	0.001	CcSEcCtD
Phenytoin—Dizziness—Vincristine—colon cancer	0.000146	0.000994	CcSEcCtD
Phenytoin—Pruritus—Fluorouracil—colon cancer	0.000145	0.000992	CcSEcCtD
Phenytoin—Confusional state—Capecitabine—colon cancer	0.000145	0.000988	CcSEcCtD
Phenytoin—Infection—Capecitabine—colon cancer	0.000143	0.000974	CcSEcCtD
Phenytoin—ABCB1—vagina—colon cancer	0.000142	0.00555	CbGeAlD
Phenytoin—Erythema multiforme—Methotrexate—colon cancer	0.000142	0.000971	CcSEcCtD
Phenytoin—Dizziness—Irinotecan—colon cancer	0.000142	0.000968	CcSEcCtD
Phenytoin—Shock—Capecitabine—colon cancer	0.000141	0.000964	CcSEcCtD
Phenytoin—Nervous system disorder—Capecitabine—colon cancer	0.000141	0.000961	CcSEcCtD
Phenytoin—Diarrhoea—Fluorouracil—colon cancer	0.000141	0.00096	CcSEcCtD
Phenytoin—Thrombocytopenia—Capecitabine—colon cancer	0.000141	0.00096	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—colon cancer	0.00014	0.000958	CcSEcCtD
Phenytoin—Tachycardia—Capecitabine—colon cancer	0.00014	0.000957	CcSEcCtD
Phenytoin—Vomiting—Vincristine—colon cancer	0.00014	0.000956	CcSEcCtD
Phenytoin—Rash—Vincristine—colon cancer	0.000139	0.000948	CcSEcCtD
Phenytoin—Hyperhidrosis—Capecitabine—colon cancer	0.000139	0.000948	CcSEcCtD
Phenytoin—Dermatitis—Vincristine—colon cancer	0.000139	0.000947	CcSEcCtD
Phenytoin—Headache—Vincristine—colon cancer	0.000138	0.000942	CcSEcCtD
Phenytoin—Anorexia—Capecitabine—colon cancer	0.000137	0.000934	CcSEcCtD
Phenytoin—Vomiting—Irinotecan—colon cancer	0.000136	0.000931	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—colon cancer	0.000136	0.000928	CcSEcCtD
Phenytoin—Dizziness—Fluorouracil—colon cancer	0.000136	0.000928	CcSEcCtD
Phenytoin—Rash—Irinotecan—colon cancer	0.000135	0.000923	CcSEcCtD
Phenytoin—Dermatitis—Irinotecan—colon cancer	0.000135	0.000923	CcSEcCtD
Phenytoin—Chills—Methotrexate—colon cancer	0.000135	0.000922	CcSEcCtD
Phenytoin—Headache—Irinotecan—colon cancer	0.000134	0.000917	CcSEcCtD
Phenytoin—Hypotension—Capecitabine—colon cancer	0.000134	0.000916	CcSEcCtD
Phenytoin—Nausea—Vincristine—colon cancer	0.000131	0.000893	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000131	0.000893	CcSEcCtD
Phenytoin—Vomiting—Fluorouracil—colon cancer	0.000131	0.000892	CcSEcCtD
Phenytoin—Insomnia—Capecitabine—colon cancer	0.00013	0.000887	CcSEcCtD
Phenytoin—Rash—Fluorouracil—colon cancer	0.00013	0.000884	CcSEcCtD
Phenytoin—Dermatitis—Fluorouracil—colon cancer	0.00013	0.000884	CcSEcCtD
Phenytoin—Paraesthesia—Capecitabine—colon cancer	0.000129	0.00088	CcSEcCtD
Phenytoin—Headache—Fluorouracil—colon cancer	0.000129	0.000879	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—colon cancer	0.000128	0.000876	CcSEcCtD
Phenytoin—Dyspnoea—Capecitabine—colon cancer	0.000128	0.000874	CcSEcCtD
Phenytoin—Nausea—Irinotecan—colon cancer	0.000128	0.00087	CcSEcCtD
Phenytoin—Back pain—Methotrexate—colon cancer	0.000127	0.000865	CcSEcCtD
Phenytoin—Dyspepsia—Capecitabine—colon cancer	0.000126	0.000863	CcSEcCtD
Phenytoin—Decreased appetite—Capecitabine—colon cancer	0.000125	0.000852	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000124	0.000846	CcSEcCtD
Phenytoin—Fatigue—Capecitabine—colon cancer	0.000124	0.000845	CcSEcCtD
Phenytoin—Constipation—Capecitabine—colon cancer	0.000123	0.000838	CcSEcCtD
Phenytoin—Nausea—Fluorouracil—colon cancer	0.000122	0.000833	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—colon cancer	0.000122	0.00083	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—colon cancer	0.000121	0.000826	CcSEcCtD
Phenytoin—ABCB1—liver—colon cancer	0.00012	0.00468	CbGeAlD
Phenytoin—Carbamazepine—ABCB1—colon cancer	0.00012	0.165	CrCbGaD
Phenytoin—Feeling abnormal—Capecitabine—colon cancer	0.000118	0.000808	CcSEcCtD
Phenytoin—Malaise—Methotrexate—colon cancer	0.000118	0.000806	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—colon cancer	0.000118	0.000803	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—colon cancer	0.000117	0.0008	CcSEcCtD
Phenytoin—Cough—Methotrexate—colon cancer	0.000114	0.00078	CcSEcCtD
Phenytoin—Urticaria—Capecitabine—colon cancer	0.000114	0.000779	CcSEcCtD
Phenytoin—Body temperature increased—Capecitabine—colon cancer	0.000114	0.000775	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—colon cancer	0.000114	0.000775	CcSEcCtD
Phenytoin—Phenobarbital—ABCB1—colon cancer	0.000112	0.154	CrCbGaD
Phenytoin—Arthralgia—Methotrexate—colon cancer	0.000112	0.000761	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—colon cancer	0.000112	0.000761	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—colon cancer	0.000112	0.000761	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—colon cancer	0.00011	0.000752	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—colon cancer	0.000108	0.000736	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—colon cancer	0.000107	0.00073	CcSEcCtD
Phenytoin—Infection—Methotrexate—colon cancer	0.000106	0.000725	CcSEcCtD
Phenytoin—Hypersensitivity—Capecitabine—colon cancer	0.000106	0.000722	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—colon cancer	0.000105	0.000716	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—colon cancer	0.000105	0.000714	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—colon cancer	0.000103	0.000705	CcSEcCtD
Phenytoin—Asthenia—Capecitabine—colon cancer	0.000103	0.000703	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—colon cancer	0.000102	0.000696	CcSEcCtD
Phenytoin—Pruritus—Capecitabine—colon cancer	0.000102	0.000693	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—colon cancer	9.99e-05	0.000682	CcSEcCtD
Phenytoin—Diarrhoea—Capecitabine—colon cancer	9.83e-05	0.000671	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—colon cancer	9.74e-05	0.000665	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—colon cancer	9.67e-05	0.00066	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—colon cancer	9.6e-05	0.000655	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—colon cancer	9.54e-05	0.000651	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—colon cancer	9.51e-05	0.000649	CcSEcCtD
Phenytoin—Dizziness—Capecitabine—colon cancer	9.5e-05	0.000648	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—colon cancer	9.42e-05	0.000642	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—colon cancer	9.3e-05	0.000634	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—colon cancer	9.23e-05	0.00063	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—colon cancer	9.22e-05	0.000629	CcSEcCtD
Phenytoin—ABCB1—lymph node—colon cancer	9.22e-05	0.00359	CbGeAlD
Phenytoin—Vomiting—Capecitabine—colon cancer	9.14e-05	0.000623	CcSEcCtD
Phenytoin—Rash—Capecitabine—colon cancer	9.06e-05	0.000618	CcSEcCtD
Phenytoin—Dermatitis—Capecitabine—colon cancer	9.05e-05	0.000617	CcSEcCtD
Phenytoin—Headache—Capecitabine—colon cancer	9e-05	0.000614	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—colon cancer	8.81e-05	0.000601	CcSEcCtD
Phenytoin—Nausea—Capecitabine—colon cancer	8.53e-05	0.000582	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—colon cancer	8.5e-05	0.00058	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—colon cancer	8.46e-05	0.000577	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—colon cancer	7.88e-05	0.000538	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—colon cancer	7.67e-05	0.000524	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—colon cancer	7.57e-05	0.000516	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—colon cancer	7.32e-05	0.000499	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—colon cancer	7.07e-05	0.000483	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—colon cancer	6.8e-05	0.000464	CcSEcCtD
Phenytoin—Rash—Methotrexate—colon cancer	6.74e-05	0.00046	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—colon cancer	6.74e-05	0.00046	CcSEcCtD
Phenytoin—Headache—Methotrexate—colon cancer	6.7e-05	0.000457	CcSEcCtD
Phenytoin—Nausea—Methotrexate—colon cancer	6.35e-05	0.000433	CcSEcCtD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.18e-05	0.00158	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—KRAS—colon cancer	2.16e-05	0.00157	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CA7—colon cancer	2.15e-05	0.00156	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	2.15e-05	0.00156	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—EGFR—colon cancer	2.1e-05	0.00152	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—EGFR—colon cancer	2.1e-05	0.00152	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—KRAS—colon cancer	2.07e-05	0.0015	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—CTNNB1—colon cancer	2.06e-05	0.00149	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—TGFB1—colon cancer	2.06e-05	0.00149	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—EGFR—colon cancer	2.03e-05	0.00147	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—EGFR—colon cancer	2.02e-05	0.00146	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CA7—colon cancer	2.01e-05	0.00146	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.01e-05	0.00145	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—KRAS—colon cancer	1.99e-05	0.00144	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—KRAS—colon cancer	1.99e-05	0.00144	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.97e-05	0.00143	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CTNNB1—colon cancer	1.97e-05	0.00143	CbGpPWpGaD
Phenytoin—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.93e-05	0.0014	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—EP300—colon cancer	1.92e-05	0.00139	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—KRAS—colon cancer	1.92e-05	0.00139	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—CASP3—colon cancer	1.91e-05	0.00138	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—KRAS—colon cancer	1.91e-05	0.00138	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CTNNB1—colon cancer	1.89e-05	0.00137	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CTNNB1—colon cancer	1.89e-05	0.00137	CbGpPWpGaD
Phenytoin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.88e-05	0.00136	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.87e-05	0.00135	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—SRC—colon cancer	1.86e-05	0.00135	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—HRAS—colon cancer	1.84e-05	0.00133	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—EP300—colon cancer	1.83e-05	0.00133	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—VEGFA—colon cancer	1.83e-05	0.00132	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CTNNB1—colon cancer	1.83e-05	0.00132	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—PPARG—colon cancer	1.82e-05	0.00132	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.82e-05	0.00132	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—VEGFA—colon cancer	1.82e-05	0.00131	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—NRAS—colon cancer	1.79e-05	0.0013	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—SRC—colon cancer	1.78e-05	0.00129	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CHST5—colon cancer	1.77e-05	0.00128	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ODC1—colon cancer	1.77e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—EP300—colon cancer	1.76e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—EP300—colon cancer	1.76e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—HRAS—colon cancer	1.76e-05	0.00127	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.75e-05	0.00127	CbGpPWpGaD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.74e-05	0.00126	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—VEGFA—colon cancer	1.74e-05	0.00126	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ODC1—colon cancer	1.73e-05	0.00125	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CHST5—colon cancer	1.73e-05	0.00125	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—NRAS—colon cancer	1.71e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—SRC—colon cancer	1.71e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—SRC—colon cancer	1.71e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—EP300—colon cancer	1.7e-05	0.00123	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—HRAS—colon cancer	1.69e-05	0.00122	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—HRAS—colon cancer	1.69e-05	0.00122	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—TGFB1—colon cancer	1.68e-05	0.00122	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—VEGFA—colon cancer	1.67e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—VEGFA—colon cancer	1.67e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—TGFB1—colon cancer	1.67e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—SRC—colon cancer	1.65e-05	0.0012	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—NRAS—colon cancer	1.65e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—NRAS—colon cancer	1.65e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—EGFR—colon cancer	1.63e-05	0.00118	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—HRAS—colon cancer	1.63e-05	0.00118	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—SRC—colon cancer	1.63e-05	0.00118	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—HRAS—colon cancer	1.62e-05	0.00117	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.62e-05	0.00117	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—colon cancer	1.61e-05	0.00117	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—VEGFA—colon cancer	1.61e-05	0.00116	CbGpPWpGaD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.6e-05	0.00116	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—TGFB1—colon cancer	1.59e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—NRAS—colon cancer	1.59e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—VEGFA—colon cancer	1.58e-05	0.00115	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.58e-05	0.00114	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.57e-05	0.00113	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—NRAS—colon cancer	1.57e-05	0.00113	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—EGFR—colon cancer	1.56e-05	0.00113	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—KRAS—colon cancer	1.54e-05	0.00112	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—TGFB1—colon cancer	1.53e-05	0.00111	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—TGFB1—colon cancer	1.53e-05	0.00111	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—EGFR—colon cancer	1.5e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—EGFR—colon cancer	1.5e-05	0.00109	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ODC1—colon cancer	1.5e-05	0.00108	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CHST5—colon cancer	1.5e-05	0.00108	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ODC1—colon cancer	1.49e-05	0.00108	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CHST5—colon cancer	1.49e-05	0.00108	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.49e-05	0.00108	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—TGFB1—colon cancer	1.48e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—KRAS—colon cancer	1.48e-05	0.00107	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—EGFR—colon cancer	1.45e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—AKT1—colon cancer	1.43e-05	0.00104	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—EGFR—colon cancer	1.43e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—KRAS—colon cancer	1.42e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—KRAS—colon cancer	1.42e-05	0.00103	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—KRAS—colon cancer	1.37e-05	0.00099	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—KRAS—colon cancer	1.35e-05	0.000975	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ODC1—colon cancer	1.34e-05	0.000968	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CHST5—colon cancer	1.34e-05	0.000968	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.34e-05	0.000968	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA7—colon cancer	1.33e-05	0.000961	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.31e-05	0.00095	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—HRAS—colon cancer	1.31e-05	0.00095	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CHST5—colon cancer	1.3e-05	0.000945	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ODC1—colon cancer	1.3e-05	0.000945	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CTNNB1—colon cancer	1.28e-05	0.00093	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ABCB1—colon cancer	1.28e-05	0.00093	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—TYMS—colon cancer	1.26e-05	0.000913	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—HRAS—colon cancer	1.25e-05	0.000908	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CHST5—colon cancer	1.22e-05	0.000882	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ODC1—colon cancer	1.22e-05	0.000882	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—HRAS—colon cancer	1.21e-05	0.000873	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—HRAS—colon cancer	1.21e-05	0.000873	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EP300—colon cancer	1.19e-05	0.000864	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.19e-05	0.000864	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—HRAS—colon cancer	1.16e-05	0.000842	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—SRC—colon cancer	1.16e-05	0.000841	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—AKT1—colon cancer	1.16e-05	0.000839	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—HRAS—colon cancer	1.15e-05	0.000829	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—VEGFA—colon cancer	1.13e-05	0.000819	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—NRAS—colon cancer	1.12e-05	0.000809	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—AKT1—colon cancer	1.11e-05	0.000802	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—AKT1—colon cancer	1.06e-05	0.000771	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—AKT1—colon cancer	1.06e-05	0.000771	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—TGFB1—colon cancer	1.04e-05	0.000751	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—AKT1—colon cancer	1.03e-05	0.000743	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EGFR—colon cancer	1.02e-05	0.000737	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.01e-05	0.000735	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.71e-06	0.000703	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—KRAS—colon cancer	9.61e-06	0.000696	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ABCB1—colon cancer	9.51e-06	0.000688	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.42e-06	0.000682	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—TYMS—colon cancer	9.34e-06	0.000676	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.17e-06	0.000664	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.08e-06	0.000657	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PPARG—colon cancer	8.94e-06	0.000647	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	8.87e-06	0.000642	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.44e-06	0.000611	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	8.4e-06	0.000608	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	8.33e-06	0.000603	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.21e-06	0.000594	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—colon cancer	8.17e-06	0.000592	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	8.12e-06	0.000588	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ODC1—colon cancer	8.04e-06	0.000582	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CHST5—colon cancer	8.04e-06	0.000582	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	7.99e-06	0.000579	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	7.45e-06	0.000539	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.35e-06	0.000532	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.34e-06	0.000531	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—AKT1—colon cancer	7.22e-06	0.000522	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.19e-06	0.000521	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—colon cancer	7.03e-06	0.000509	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.79e-06	0.000492	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PPARG—colon cancer	6.61e-06	0.000479	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	6.34e-06	0.000459	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ABCB1—colon cancer	6.32e-06	0.000458	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.24e-06	0.000452	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—TYMS—colon cancer	6.21e-06	0.000449	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.18e-06	0.000448	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.15e-06	0.000445	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.04e-06	0.000437	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—EP300—colon cancer	5.85e-06	0.000423	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.52e-06	0.0004	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—colon cancer	5.2e-06	0.000377	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	5.18e-06	0.000375	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.1e-06	0.000369	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.03e-06	0.000364	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.86e-06	0.000352	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.84e-06	0.00035	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—colon cancer	4.67e-06	0.000338	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—TYMS—colon cancer	4.59e-06	0.000332	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—colon cancer	4.57e-06	0.000331	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—TYMS—colon cancer	4.49e-06	0.000325	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—EP300—colon cancer	4.42e-06	0.00032	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PPARG—colon cancer	4.4e-06	0.000318	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.34e-06	0.000314	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—EP300—colon cancer	4.33e-06	0.000313	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CA—colon cancer	4.32e-06	0.000313	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SRC—colon cancer	4.3e-06	0.000311	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—colon cancer	4.18e-06	0.000303	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—colon cancer	4.13e-06	0.000299	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.04e-06	0.000293	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.02e-06	0.000291	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.96e-06	0.000287	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—colon cancer	3.96e-06	0.000287	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—colon cancer	3.93e-06	0.000285	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TYMS—colon cancer	3.89e-06	0.000281	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TYMS—colon cancer	3.86e-06	0.00028	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TGFB1—colon cancer	3.84e-06	0.000278	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.61e-06	0.000261	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—colon cancer	3.56e-06	0.000258	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AKT1—colon cancer	3.53e-06	0.000256	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—colon cancer	3.53e-06	0.000256	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMS—colon cancer	3.47e-06	0.000251	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—colon cancer	3.46e-06	0.00025	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMS—colon cancer	3.39e-06	0.000245	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.29e-06	0.000238	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—colon cancer	3.27e-06	0.000237	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PPARG—colon cancer	3.25e-06	0.000235	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—colon cancer	3.22e-06	0.000233	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—colon cancer	3.2e-06	0.000232	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PPARG—colon cancer	3.18e-06	0.00023	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMS—colon cancer	3.16e-06	0.000229	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—colon cancer	3.16e-06	0.000229	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—colon cancer	3.02e-06	0.000219	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.99e-06	0.000217	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.98e-06	0.000215	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—EP300—colon cancer	2.88e-06	0.000208	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPARG—colon cancer	2.75e-06	0.000199	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPARG—colon cancer	2.74e-06	0.000198	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.67e-06	0.000193	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—AKT1—colon cancer	2.67e-06	0.000193	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AKT1—colon cancer	2.62e-06	0.000189	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—colon cancer	2.56e-06	0.000185	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—colon cancer	2.5e-06	0.000181	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPARG—colon cancer	2.46e-06	0.000178	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.44e-06	0.000176	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPARG—colon cancer	2.4e-06	0.000174	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPARG—colon cancer	2.24e-06	0.000162	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—colon cancer	2.17e-06	0.000157	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—colon cancer	2.15e-06	0.000156	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—colon cancer	2.13e-06	0.000154	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—EP300—colon cancer	2.13e-06	0.000154	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—colon cancer	2.12e-06	0.000154	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMS—colon cancer	2.09e-06	0.000151	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—EP300—colon cancer	2.08e-06	0.000151	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—colon cancer	1.93e-06	0.00014	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—colon cancer	1.89e-06	0.000137	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—EP300—colon cancer	1.8e-06	0.00013	CbGpPWpGaD
Phenytoin—ALB—Metabolism—EP300—colon cancer	1.79e-06	0.00013	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—colon cancer	1.76e-06	0.000128	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AKT1—colon cancer	1.74e-06	0.000126	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—EP300—colon cancer	1.61e-06	0.000116	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—colon cancer	1.57e-06	0.000114	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—EP300—colon cancer	1.57e-06	0.000114	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—colon cancer	1.54e-06	0.000111	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPARG—colon cancer	1.48e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—EP300—colon cancer	1.47e-06	0.000106	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—colon cancer	1.33e-06	9.65e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—colon cancer	1.32e-06	9.59e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AKT1—colon cancer	1.29e-06	9.31e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AKT1—colon cancer	1.26e-06	9.1e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—colon cancer	1.19e-06	8.61e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—colon cancer	1.16e-06	8.42e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—colon cancer	1.16e-06	8.4e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AKT1—colon cancer	1.09e-06	7.88e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—colon cancer	1.08e-06	7.85e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AKT1—colon cancer	1.08e-06	7.84e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AKT1—colon cancer	9.72e-07	7.03e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—EP300—colon cancer	9.67e-07	7e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AKT1—colon cancer	9.48e-07	6.87e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AKT1—colon cancer	8.86e-07	6.41e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—colon cancer	7.15e-07	5.18e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKT1—colon cancer	5.84e-07	4.23e-05	CbGpPWpGaD
